Mark Rothera - Sep 19, 2022 Form 3 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Daniel Chevallard, as Attorney-in-Fact
Stock symbol
VIRX
Transactions as of
Sep 19, 2022
Transactions value $
$0
Form type
3
Date filed
9/19/2022, 06:54 PM
Next filing
Mar 17, 2023

No securities are beneficially owned.

Remarks:

No securities beneficially held.